Associate Director HEOR Hematology (a)

Your main tasks include:

• Supporting and managing HEOR activities across hematology assets in Europe and New Markets, delivering evidence for HTA, reimbursement, and broader evidence needs.
• Collaborating with cross-functional teams to identify evidence gaps and prioritize HEOR activities based on regional and local requirements.
• Developing and executing HEOR evidence-generation activities, including comparative effectiveness research, real-world evidence, and economic analyses.
• Supporting the development, review, and quality assurance of HEOR studies and deliverables, including protocols, analysis plans, reports, and publications.
• Contributing to European HTA and EU Joint Clinical Assessment (JCA) strategies, including planning and executing required evidence-generation activities.
• Supporting JCA PICO planning by assessing populations, subgroups, comparators, outcomes, evidence gaps, and feasibility considerations.
• Leading or supporting comparative evidence generation for JCA and other HTA requirements.
• Evaluating clinical, external, and real-world data with internal and external stakeholders to address evidence gaps and inform evidence-generation approaches.
• Managing external HEOR vendors and projects, overseeing scope, methodology, timelines, deliverables, and quality control.
• Supporting the interpretation and communication of HEOR evidence, including methodological considerations and implications for HTA decision-making.
• Providing additional HEOR support across the hematology portfolio as business priorities evolve.

• Master's degree or PhD in Health Economics, Outcomes Research, Epidemiology, Public Health, Statistics or a related discipline.
• 5+ years of relevant experience in HEOR, HTA, RWE or comparative effectiveness research, preferably within the pharmaceutical industry or consulting.
• Good understanding of European HTA and evidence requirements; knowledge or experience with the EU HTA Regulation and JCA would be a strong asset.
• Experience with comparative effectiveness methods such as ITC/NMA and population-adjusted approaches (e.g. MAIC/STC) would be highly desirable.
• Experience designing, managing and critically reviewing HEOR studies and working with external research vendors.
• Knowledge or experience in hematology/oncology would be an asset.
• Strong analytical and critical-thinking skills, with the ability to translate evidence gaps into practical research activities.
• Ability to work effectively in a cross-functional matrix environment and manage multiple projects and changing priorities.
• Excellent written and verbal communication skills in English.
• Highly organized, proactive and able to work independently in a fast-paced environment.

• Working on high-impact HEOR projects supporting innovative hematology therapies across Europe.
• Gaining hands-on experience in HTA, EU JCA, real-world evidence, and market access strategy.
• Joining a collaborative international team in Basel on a flexible 6-month assignment.